This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): MELACINE
Description: Melacine is an allogeneic melanoma tumor cell lysate vaccine.
Partners: Bayer AG
Pink Sheet Schering ends Melacine comarketing agreement
Pink Sheet Corixa Melacine Phase III trial design
Pink Sheet Ribi ImmunoChem
Additional information available to subscribers only: